Estrone Sulfate: Production Rate and Metabolism in Man
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Since estrone sulfate (E(1)S) is present at high concentration in plasma, we have examined the parameters of the plasma estrone, estradiol, E(1)S system. The metabolic clearance rate of E(1)S was 157 liter/day (range 70-292) in men and women. Estimated plasma production rates of E(1)S were (mugrams per day): men, 77; women, early follicular phase, 95; women, early luteal phase, 182. The conversion of plasma estrone and estradiol to E(1)S was measured and from these data and the metabolic clearance rates of the estrogens, the transfer factors were rho(E) (1) (E) (1) (S) = 0.54 and rho(E) (2) (E) (1) (S) = 0.65. Using average production rates, all plasma E(1)S could be shown to be derived from plasma estrone and estradiol. The conversion of plasma E(1)S to plasma estrone and estradiol was studied. The calculated transfer factors were: rho(E) (1) (SE) (1) = 0.21, rho(E) (1) (SE) (2) = 0.014. Essentially, similar data were obtained when E(1)S was given by mouth to two subjects. WE CONCLUDE: (a) E(1)S is a major circulating plasma estrogen and has a long plasma half-life; (b) the large contributions of estrone and estradiol to plasma E(1)S are more than sufficient to account for all the circulating plasma E(1)S.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Horton, R., & Tait, J. F. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105344 · Cited by 401
Bardin, C. W., & Lipsett, M. B. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105588 · Cited by 322
Self-citationThe measurement of estrone sulfate in plasma
LORIAUX, D., RUDER, H., & LIPSETT, M. (1971) · Steroids · doi:10.1016/0039-128x(71)90059-6 · Cited by 186
Self-citationBAIRD, D. T., & GUEVARA, A. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-2-149 · Cited by 176
A Radio-ligand Binding Assay System for Estradiol Measurement in Human Plasma
KORENMAN, S. G., PERRIN, L. E., & McCALLUM, T. P. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-7-879 · Cited by 175
The binding of steroids and steroid conjugates to human plasma proteins.
Sandberg, A. A., Slaunwhite, W. R., & Antoniades, H. N. (1957) · PubMed · Cited by 169
Longcope, C., Layne, D. S., & Tait, J. F. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105718 · Cited by 167
Metabolic clearance and blood production rates of estrogens in postmenopausal women
Longcope, C. (1971) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(71)90488-1 · Cited by 165
Effects of Induced Hyperthyroidism on Steroid Metabolism in Man
RUDER, H., CORVOL, P., MAHOUDEAU, J. A., ROSS, G. T., & LIPSETT, M. B. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-3-382 · Cited by 139
Self-citationThe Metabolism of Estrone Sulfate in Normal Males
Longcope, C. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-1-113 · Cited by 123
Cited by
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 971
Steroid sulfatase: molecular biology, regulation, and inhibition
Reed, M. J., Purohit, A., Woo, L. W. L., Newman, S. P., & Potter, B. V. L. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0003 · Cited by 524
Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay.
Klein, K. O., Baron, J., Colli, M. J., McDonnell, D. P., & Cutler, G. B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117616 · Cited by 377
SANTEN, R. J., SANTNER, S., DAVIS, B., VELDHUIS, J., SAMOJLIK, E., & RUBY, E. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-6-1257 · Cited by 342
Anticancer steroids: linking natural and semi-synthetic compounds
Salvador, J. A. R., Carvalho, J. F. S., Neves, M. A. C., Silvestre, S. M., Leitão, A. J., Silva, M. M. C., & Sá e Melo, M. L. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20082a · Cited by 276
Serum Hormones and the Alcohol-Breast Cancer Association in Postmenopausal Women
Dorgan, J. F., Baer, D. J., Albert, P. S., Judd, J. T., Brown, E. D., Corle, D. K., Campbell, W. S., Hartman, T. J., Tejpar, A. A., Clevidence, B. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.710 · Cited by 263
Exposure to exogenous estrogens in food: possible impact on human development and health
Andersson, A., & Skakkebaek, N. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400477 · Cited by 253
From pregnancy to preeclampsia: a key role for estrogens
Berkane, N., Liere, P., Oudinet, J.-P., Hertig, A., Lefèvre, G., Pluchino, N., Schumacher, M., & Chabbert-Buffet, N. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1065 · Cited by 223
Current status on development of steroids as anticancer agents
Gupta, A., Sathish Kumar, B., & Negi, A. S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.011 · Cited by 216
The selective estrogen enzyme modulators in breast cancer: a review
Pasqualini, J. R. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.03.001 · Cited by 192
“, 1972 [48] 0.”
Influentialvan der Deure, W. M., Peeters, R. P., & Visser, T. J. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0042 · Cited by 130
“E1S is thought to serve as a reservoir for active estrogens, for instance in breast tissue, since serum concentrations of E1S are 10–20 times higher than those of the unconjugated estrogens (Ruder et al. 1972).”
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
Purohit, A., & Foster, P. A. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0266 · Cited by 126
“As mentioned above, breast tumor tissue of postmenopausal women can have as much as ten times the estrogen levels compared with plasma samples from the same patients (Ruder et al. 1972).”
Noel, C. T., Reed, M. J., Jacobs, H. S., & James, V. H. T. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90039-x · Cited by 94
Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma
Utsunomiya, H., Ito, K., Suzuki, T., Kitamura, T., Kaneko, C., Nakata, T., Niikura, H., Okamura, K., Yaegashi, N., & Sasano, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0040 · Cited by 85
“E1S and E2S have a relatively long half-life in the peripheral blood (10), where serum levels of E1S and E2S are known to be 10-fold higher than those of unconjugated E1 or 17 -estradiol (11).”
BackgroundCASEY, M. L., & MacDONALD, P. C. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-4-396 · Cited by 82
Marchand, G. B., Carreau, A.-M., Weisnagel, S. J., Bergeron, J., Labrie, F., Lemieux, S., & Tchernof, A. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00293.2017 · Cited by 73
Potter, B. V. L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0045 · Cited by 73
Steroid sulphatase and its inhibitors: past, present, and future
Foster, P. A. (2021) · Molecules · doi:10.3390/molecules26102852 · Cited by 49
“Furthermore, due to their binding to serum albumin, steroid sulphates have a much longer half-life in blood (10–12 h), compared to unconjugated oestrogens (20–30 min) [19].”
BackgroundTOWOBOLA, O. A., CRILLY, R. C., & OAKEY, R. E. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb03412.x · Cited by 18
Metadata
- Authors
- Ruder, H. J., Loriaux, L., & Lipsett, M. B.
- Venue
- Journal of Clinical Investigation
- Published
- 1972-04-01
- Volume
- 51
- Issue
- 4
- Pages
- 1020-1033
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2144862051
- Cited by
- 257
- References
- 27
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.